BTSG insider ownership: who sold, why, and what they still hold

What stands out

Three officers sold $38.5M with no disclosed plan: Jon Rousseau ($31.1M), Lisa Nalley ($3.9M) and Jennifer Phipps ($3.5M). The filings don't state a reason.Jon Rousseau: largest such sale, Mar 4, 2026 · Lisa Nalley: largest such sale, Jun 5, 2026 · Jennifer Phipps: largest such sale, Jun 5, 2026

Outside holders and shareholders represented on the board, not part of management, sold heavily: KKR Phoenix Aggregator L.P. ($2.09B) and KKR Group Partnership L.P. ($2.09B).KKR Phoenix Aggregator L.P.: largest sale, Jun 5, 2026 · KKR Group Partnership L.P.: largest sale, Jun 5, 2026

A share of stake is shown for 0 of the 4 officers and directors who sold. 10 are left out

Left out: Jon Rousseau, Jennifer Phipps, Michael McMaude, Lisa Nalley, Robert Barnes, Olivia Kirtley, Steven Miller, Timothy Wicks, Scott Greenwell and Nigam Shah (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Jon Rousseau

Chairman, President and Chief Executive Officer, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$31.1MNo plan disclosed

Lisa Nalley

Chief of Staff and Senior Vice President, Human Resources

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$3.9MNo plan disclosed

Jennifer Phipps

Chief Financial Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$3.5MNo plan disclosed

Scott Greenwell

President, PharMerica

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$874KDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Sep 14, 2026Scott Greenwell sold 15K shares ($874K) under a disclosed trading plan. 12K shares came in from vesting or option exercises the same day, so the holding fell by 3.1K net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Scott Greenwell President, PharMerica	15,099	$57.91	n/a	n/a	Sep 14, 2026	Sep 16, 2026

Outside holders, reported separately

KKR Phoenix Aggregator L.P. sold $2.09B and KKR Group Partnership L.P. sold $2.09B in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the BrightSpring Health Services, Inc. CEO selling stock?

Yes. Jon Rousseau sold 715K shares ($31.1M) in the past 12 months, none of it under a trading plan disclosed in the filings.

Why are BrightSpring Health Services, Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 2% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 98% had no disclosed plan. A trading plan schedules sales in advance.

Are any BrightSpring Health Services, Inc. insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold4 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Jon Rousseau Chairman, President and Chief Executive Officer, Director	$31.1M 715K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Lisa Nalley Chief of Staff and Senior Vice President, Human Resources	$3.9M 85K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Jennifer Phipps Chief Financial Officer	$3.5M 70K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Scott Greenwell President, PharMerica	$874K 15K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

Outside holder, reported separately: KKR Phoenix Aggregator L.P. (a 10% owner, not part of management). Sold $2.09B (49.13M shares) from Oct 22, 2025 to Jun 5, 2026. Latest filing

Outside holder, reported separately: KKR Group Partnership L.P. (a 10% owner, not part of management). Sold $2.09B (49.13M shares) from Oct 22, 2025 to Jun 5, 2026. Latest filing

The full ownership picture0 of 10 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 16, 2025

Sold

Held Oct 16, 2026

Still held

Jon Rousseau

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jon Rousseau are complete.

Chairman, President and Chief Executive Officer, Director

n/a

−715K

n/a

Vesting, gifts, unvested awards and holding lines for Jon Rousseau

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jon Rousseau are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−181Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,166,064	$6.37	Oct 16, 2029	$60.1M
254,651	$22.29	Nov 22, 2033	$9.1M
320,086	$13.00	Jan 25, 2034	$14.4M
733,496	$17.45	Mar 17, 2035	$29.7M
458,008	$41.77	Mar 5, 2036	$7.4M
404,676	$6.37	Oct 16, 2029	$20.9M
192,704	$22.29	Nov 22, 2033	$6.9M
377,602	$6.37	Oct 16, 2029	$19.5M
180,753	$22.29	Nov 22, 2033	$6.4M

Estimate: options held × ($57.91 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Jennifer Phipps

Chief Financial Officer

n/a

−70K

n/a

Vesting, gifts, unvested awards and holding lines for Jennifer Phipps

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jennifer Phipps are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−33Kwithheld by the company for taxes

Some sales match sales reported by Lisa Nalley exactly (date, shares and price). Possibly the same shares reported by both; the filings don't confirm it.

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
55,708	$6.37	Sep 24, 2029	$2.9M
23,543	$7.01	May 12, 2030	$1.2M
52,509	$13.00	Jan 25, 2034	$2.4M
17,665	$7.01	May 12, 2030	$899K
183,374	$17.45	Mar 17, 2035	$7.4M
130,860	$41.77	Mar 5, 2036	$2.1M

Estimate: options held × ($57.91 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Michael McMaude

President, Hospice Services

n/a

Vesting, gifts, unvested awards and holding lines for Michael McMaude

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Michael McMaude are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
103,048	$15.92	May 12, 2031	$4.3M
18,670	$13.00	Jan 25, 2034	$838K

Estimate: options held × ($57.91 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Lisa Nalley

Chief of Staff and Senior Vice President, Human Resources

n/a

−85K

n/a

Vesting, gifts, unvested awards and holding lines for Lisa Nalley

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Lisa Nalley are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−21Kwithheld by the company for taxes

Some sales match sales reported by Jennifer Phipps exactly (date, shares and price). Possibly the same shares reported by both; the filings don't confirm it.

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
41,909	$6.37	Sep 24, 2029	$2.2M
15,702	$7.01	May 12, 2030	$799K
35,006	$13.00	Jan 25, 2034	$1.6M
97,800	$17.45	Mar 17, 2035	$4.0M
52,344	$41.77	Mar 5, 2036	$845K

Estimate: options held × ($57.91 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Robert Barnes

President, Community Living

n/a

Vesting, gifts, unvested awards and holding lines for Robert Barnes

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Robert Barnes are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−14Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
113,718	$6.37	Sep 24, 2029	$5.9M
11,776	$7.01	May 12, 2030	$599K
16,919	$13.00	Jan 25, 2034	$760K

Estimate: options held × ($57.91 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Olivia Kirtley

Director

n/a

Vesting, gifts, unvested awards and holding lines for Olivia Kirtley

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Olivia Kirtley are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Steven Miller

Director

n/a

Vesting, gifts, unvested awards and holding lines for Steven Miller

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Steven Miller are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−4.5Kwithheld by the company for taxes

Timothy Wicks

Director

n/a

Vesting, gifts, unvested awards and holding lines for Timothy Wicks

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Timothy Wicks are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Scott Greenwell

President, PharMerica

n/a

−15K

n/a

Vesting, gifts, unvested awards and holding lines for Scott Greenwell

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Scott Greenwell are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−2.5Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
23,947	$22.27	Jun 20, 2035	$853K
49,073	$41.77	Mar 5, 2036	$792K

Estimate: options held × ($57.91 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Nigam Shah

Director

n/a

Vesting, gifts, unvested awards and holding lines for Nigam Shah

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Nigam Shah are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for BrightSpring Health Services, Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$39.3M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $39.3M across 885,099 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $874K · 2%

98%

The lighter segment is sales with no plan disclosed in the filing ($38.5M), including tax-related sales outside a plan.

No plan disclosed · $38.5M

Sales with no 10b5-1 plan and no tax reference in the filing. $31.1M of it is Jon Rousseau. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Jon Rousseau, Mar 4, 2026

Taxes

255,041 shares ($11.8M) were withheld by the company for taxes, which isn't a market sale.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Jon Rousseau Chairman, President and Chief Executive Officer, Director	715K	$31.1M	0%	79%	Oct 22, 2025 to Jun 5, 2026
Lisa Nalley Chief of Staff and Senior Vice President, Human Resources	85K	$3.9M	0%	10%	Oct 22, 2025 to Jun 5, 2026
Jennifer Phipps Chief Financial Officer	70K	$3.5M	0%	9%	Mar 4, 2026 to Jun 5, 2026
Scott Greenwell President, PharMerica	15K	$874K	100%	2%	Sep 14, 2026 to Sep 14, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$7.3M	$0	$0	$7.3M
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$11.7M	$0	$0	$11.7M
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$19.4M	$0	$0	$19.4M
Jul 2026	$0	$0	$0	$0
Aug 2026	$0	$0	$0	$0
Sep 2026	$874K	$874K	$0	$0
Oct 2026	$0	$0	$0	$0

Known gaps and uncertainty10 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for BrightSpring Health Services, Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology107 filings on record, 34 filed in the 12-month period, and how we read them

All 107 Forms 3, 4 and 5 on record for BrightSpring Health Services, Inc. (SEC CIK 1865782), filed from Jan 26, 2024 to Sep 16, 2026; 34 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (8)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Jennifer Yowler	Mar 19, 2025	75,401 shares, last reported balance as of Mar 17, 2025
Walgreens Boots Alliance, Inc.	Feb 20, 2025	11,239,996 shares, last reported balance as of Feb 18, 2025
James Mattingly Jr.	Jan 28, 2025	122,665 shares, last reported balance as of Jan 25, 2025
Matthew DAmbrosio	May 21, 2024	1,000 shares, last reported balance as of May 20, 2024
Steven Reed	Jan 30, 2024	93,914 shares, last reported balance as of Jan 26, 2024
Max Lin		No balance on record
Johnny Kim		No balance on record
Hunter Craig		No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

BrightSpring Health Services, Inc. insiders sold $39.3M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Outside holders, reported separately

Common questions

Is the BrightSpring Health Services, Inc. CEO selling stock?

Why are BrightSpring Health Services, Inc. insiders selling?

Are any BrightSpring Health Services, Inc. insiders buying?

The evidence

No plan disclosed · $38.5M

Taxes

Sales by month